Utility of RET mutant in diagnosis and treatment of melanoma
Document Type
Patent
Publication Date
11-7-2008
Abstract
The invention relates to a method of detecting a RET mutant in a melanoma cell. Also disclosed is a method of modulating the activity of a RET mutant in a melanoma cell with an agent that interferes with the activity of the RET mutant.
Area of Special Interest
Cancer
Specialty/Research Institute
Oncology
Location
United States
Assignee
John Wayne Cancer Institute (Santa Monica, CA)
Family ID
40626214
Serial Number
12/267,541
Tech ID
07-JWCI-057
COinS
Comments
Patent Number: 7,943,319